Reply to "Response: Distinguishing Stevens-Johnson syndrome/toxic epidermal necrolysis from clinical mimickers during inpatient dermatologic consultation - a retrospective chart review."
暂无分享,去创建一个
[1] A. Kirkorian,et al. The national burden of inpatient dermatology in adults. , 2019, Journal of the American Academy of Dermatology.
[2] B. Kaffenberger,et al. Association of Dermatology Consultations With Patient Care Outcomes in Hospitalized Patients With Inflammatory Skin Diseases , 2017, JAMA dermatology.
[3] J. Silverberg,et al. Morbidity and Mortality of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in United States Adults. , 2016, The Journal of investigative dermatology.
[4] J. Dokter,et al. Epidemiology and costs of patients with toxic epidermal necrolysis: a 27‐year retrospective study , 2015, Journal of the European Academy of Dermatology and Venereology.
[5] C. Nelson,et al. The reliability of teledermatology to triage inpatient dermatology consultations. , 2014, JAMA dermatology.